Polycystic Ovary Syndrome
Conditions
Interventions
treatment group:The treatment group will receive the Jianpi Qushi Huatan Decoction (consisting of Radix astragali, Atractylodes Lancea, Dioscorea oppositifolia, Cyperus rotundus, Lindera aggregata, A
placebo group:The control group receives a placebo treatment, and both the treatment group and the control group are provided with medications that are uniformly packaged, with identical appearance, s
Sponsors
The Second Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: (1) Patients diagnosed with PCOS were diagnosed according to the 2023 International Evidence-Based Guidelines; (2) In line with PCOS kidney-yang deficiency phlegm-dampness-blood stasis type syndrome differentiation criteria; ? Age: 18 ~ 40 years old, no fertility requirements; ? Willing to treat according to the treatment plan prescribed in this subject.
Exclusion criteria
Exclusion criteria: ? Hyperprolactinemia: Two serum prolactin levels = 25ng/ml, at least one week apart. ? Diminished ovarian reserve, FSH > 10 IU/L. ? Abnormal thyroid function, TSH 5.5 mIU/mL. ? Hypothalamic-pituitary amenorrhea. ? Suspected Cushing's syndrome patients. ? Patients suspected of secreting androgens due to adrenal or ovarian tumors. ? Specific family history of hirsutism. ? Poorly controlled type II diabetes patients. ? Pregnant or lactating women. ? Poorly controlled hypertension patients, with systolic blood pressure = 160 mmHg or diastolic blood pressure = 100 mmHg. Recent use of hormonal or other medications that may affect the results within the past 3 months. Presence of severe or acute conditions affecting the heart, liver, kidneys, blood, etc. Unwillingness to sign the informed consent form for this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ovulation rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| BMI;WHR;Ferriman-Gallwey hirsutism rating scale;Acne Pillsbury rating scale;Ludwig visual score evaluation criteria for androgenetic hair loss;menstruation;OGTT;gonadal hormone concentrations;Ovary size and number of follicles;PCOSQ;HADS;FSFI;Androgen level;glycosylated hemoglobin;thyrotropin;blood lipid; | — |
Countries
china
Contacts
Public ContactRuining Liang
The Second Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine
Outcome results
None listed